Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Viracta Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results. Also, the company announced its Phase 2 NAVAL-1 trial results and will begin a randomized controlled trial (RCT).

Author: Benzinga Newsdesk | August 14, 2024 08:22am

Posted In: VIRX